Blue Moon Metals (MOON) Stock Chart & Stock Price History → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free MOON Stock Alerts C$0.04 -0.01 (-10.00%) (As of 05:18 PM ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Blue Moon Metals Stock Price Performance5 Day Performance-10.00%1 Month Performance-25.00%3 Month Performance-35.71%6 Month Performance-18.18%Year-To-Date Performance-18.18%1 Year Performance-43.75% Receive MOON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Blue Moon Metals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> MOON Stock Chart for Thursday, April, 25, 2024 MOON Chart by TradingView Blue Moon Metals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024C$0.05C$0.05C$0.05C$0.053,000 shsC$1.19 million04/24/2024C$0.05C$0.05C$0.05C$0.0439,917 shsC$1.19 million04/23/2024C$0.05C$0.05C$0.05C$0.0439,917 shsC$1.19 million04/22/2024C$0.05C$0.05-10.00%C$0.05C$0.0439,917 shsC$1.19 million04/19/2024C$0.05C$0.05C$0.05C$0.0532,000 shsC$1.32 million04/18/2024C$0.05C$0.05C$0.05C$0.0532,000 shsC$1.32 million Get the Latest News and Ratings for MOON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Blue Moon Metals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024C$0.06C$0.05-9.09%C$0.05C$0.0532,000 shsC$1.32 million04/16/2024C$0.06C$0.06C$0.06C$0.062,000 shsC$1.45 million04/15/2024C$0.06C$0.06-8.33%C$0.06C$0.0679,000 shsC$1.45 million04/12/2024C$0.06C$0.06C$0.06C$0.067,000 shsC$1.58 million04/11/2024C$0.06C$0.06C$0.06C$0.062,000 shsC$1.58 million04/10/2024C$0.06C$0.06C$0.06C$0.062,000 shsC$1.58 million04/09/2024C$0.06C$0.06+9.09%C$0.06C$0.0610,000 shsC$1.58 million04/08/2024C$0.06C$0.06C$0.06C$0.0611,000 shsC$1.45 million04/05/2024C$0.06C$0.06C$0.06C$0.067,600 shsC$1.45 million04/04/2024C$0.06C$0.06C$0.06C$0.066,000 shsC$1.45 million04/03/2024C$0.06C$0.06C$0.06C$0.066,000 shsC$1.45 million04/02/2024C$0.06C$0.06C$0.06C$0.066,000 shsC$1.45 million04/01/2024C$0.06C$0.06C$0.06C$0.066,000 shsC$1.45 million03/29/2024C$0.06C$0.06C$0.06C$0.066,000 shsC$1.45 million03/28/2024C$0.06C$0.06-8.33%C$0.06C$0.066,000 shsC$1.45 million03/27/2024C$0.06C$0.06C$0.06C$0.0648,038 shsC$1.58 million03/26/2024C$0.06C$0.06C$0.06C$0.0648,038 shsC$1.58 million03/25/2024C$0.06C$0.06C$0.06C$0.0648,038 shsC$1.58 million03/22/2024C$0.06C$0.06C$0.06C$0.0648,040 shsC$1.58 million03/21/2024C$0.07C$0.06-7.69%C$0.06C$0.0648,040 shsC$1.58 million03/20/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/19/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/18/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/15/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/14/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/13/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/12/2024C$0.07C$0.07C$0.07C$0.071,000 shsC$1.72 million03/11/2024C$0.06C$0.07+18.18%C$0.07C$0.071,000 shsC$1.72 million03/08/2024C$0.06C$0.06C$0.06C$0.0646,000 shsC$1.45 million03/07/2024C$0.06C$0.06C$0.06C$0.0646,000 shsC$1.45 million03/06/2024C$0.06C$0.06C$0.06C$0.0646,000 shsC$1.45 million03/05/2024C$0.06C$0.06C$0.06C$0.0646,000 shsC$1.45 million03/04/2024C$0.07C$0.06-15.38%C$0.06C$0.0646,000 shsC$1.45 million03/01/2024C$0.06C$0.07+18.18%C$0.07C$0.0615,000 shsC$1.72 millionThe World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>>02/29/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$1.45 million02/28/2024C$0.06C$0.06-8.33%C$0.06C$0.065,000 shsC$1.45 million02/27/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$1.58 million02/26/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$1.58 million02/23/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$1.58 million02/22/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$1.58 million02/21/2024C$0.06C$0.06C$0.06C$0.066,001 shsC$1.58 million02/20/2024C$0.06C$0.06C$0.06C$0.066,001 shsC$1.58 million02/19/2024C$0.06C$0.06C$0.06C$0.066,001 shsC$1.58 million02/16/2024C$0.06C$0.06C$0.06C$0.066,001 shsC$1.58 million02/15/2024C$0.06C$0.06C$0.06C$0.061,000 shsC$1.58 million02/14/2024C$0.06C$0.06C$0.06C$0.061,000 shsC$1.58 million02/13/2024C$0.06C$0.06C$0.06C$0.061,000 shsC$1.58 million02/12/2024C$0.06C$0.06C$0.06C$0.061,000 shsC$1.58 million02/09/2024C$0.06C$0.06C$0.06C$0.061,000 shsC$1.58 million02/08/2024C$0.06C$0.06+9.09%C$0.06C$0.061,000 shsC$1.58 million02/07/2024C$0.06C$0.06C$0.06C$0.065,470 shsC$1.45 million02/06/2024C$0.06C$0.06C$0.06C$0.065,470 shsC$1.45 million02/05/2024C$0.06C$0.06C$0.06C$0.065,470 shsC$1.45 million02/02/2024C$0.07C$0.06-21.43%C$0.06C$0.065,470 shsC$1.45 million02/01/2024C$0.07C$0.07C$0.07C$0.079,600 shsC$1.85 million01/31/2024C$0.07C$0.07C$0.07C$0.079,600 shsC$1.85 million01/30/2024C$0.07C$0.07C$0.07C$0.079,600 shsC$1.85 million01/29/2024C$0.07C$0.07C$0.07C$0.079,600 shsC$1.85 million01/26/2024C$0.07C$0.07C$0.07C$0.079,600 shsC$1.85 million01/25/2024C$0.07C$0.07C$0.07C$0.079,600 shsC$1.85 million01/24/2024C$0.06C$0.07+16.67%C$0.07C$0.079,600 shsC$1.85 million Related Companies: Orestone Mining Stock Chart Nevada Zinc Stock Chart Avrupa Minerals Stock Chart Rainy Mountain Royalty Stock Chart Nortec Minerals Stock Chart Select Sands Stock Chart Jaxon Mining Stock Chart CaNickel Mining Stock Chart Mineral Hill Industries Stock Chart K9 Gold Stock Chart Receive MOON Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Blue Moon Metals and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:MOON) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blue Moon Metals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
